NCM
Nantahala Capital Management Portfolio holdings
AUM
$1.41B
This Quarter Return
+8.83%
1 Year Return
+32.9%
3 Year Return
+104.34%
5 Year Return
+145.08%
10 Year Return
+443.66%
AUM
$824M
AUM Growth
+$824M
(-21%)
Cap. Flow
-$249M
Cap. Flow
% of AUM
-30.16%
Top 10 Holdings %
Top 10 Hldgs %
50.4%
Holding
132
New
16
Increased
19
Reduced
47
Closed
17
Top Buys
| 1 |
The Bancorp
TBBK
|
$13.3M |
| 2 |
Lyra Therapeutics
LYRA
|
$7.14M |
| 3 |
Amneal Pharmaceuticals
AMRX
|
$5.11M |
| 4 |
Cytokinetics
CYTK
|
$4.87M |
| 5 |
InspireMD
NSPR
|
$4.67M |
Top Sells
| 1 |
TA
TravelCenters of America LLC
TA
|
$51.7M |
| 2 |
APEN
Apollo Endosurgery, Inc.
APEN
|
$45.4M |
| 3 |
iShares Russell 2000 ETF
IWM
|
$25.2M |
| 4 |
Travel + Leisure Co
TNL
|
$24.4M |
| 5 |
Syndax Pharmaceuticals
SNDX
|
$13.7M |
Sector Composition
| 1 | Healthcare | 51.51% |
| 2 | Financials | 11.55% |
| 3 | Consumer Discretionary | 11.31% |
| 4 | Communication Services | 8.45% |
| 5 | Industrials | 6.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Jasper Therapeutics
JSPR
$44.2M
| $3.39M | 0.33% |
2,477,880
+789,426
| +47% | +$1.08M |
|
52
Noodles & Co
NDLS
$31M
| $3.38M | 0.33% |
+1,000,000
| New | +$3.38M |
|
|
OPTN
53
DELISTED
OptiNose
OPTN
| $3.3M | 0.32% |
2,681,667
+1,231,667
| +85% | +$1.51M |
|
|
IMTXW
54
DELISTED
Immatics N.V. Warrants
IMTXW
| $3.23M | 0.31% |
986,101
| – | – |
|
|
AGS
55
DELISTED
PlayAGS
AGS
| $3.12M | 0.3% |
552,513
+56,000
| +11% | +$316K |
|
56
B. Riley Financial
RILY
$164M
| $2.87M | 0.28% |
62,520
| – | – |
|
57
Enova International
ENVA
$3B
| $2.83M | 0.27% |
53,250
| – | – |
|
58
Soleno Therapeutics
SLNO
$3.56B
| $2.79M | 0.27% |
649,841
-49,523
| -7% | -$212K |
|
59
C4 Therapeutics
CCCC
$182M
| $2.75M | 0.27% |
+1,000,000
| New | +$2.75M |
|
60
Fossil Group
FOSL
$175M
| $2.36M | 0.23% |
+920,180
| New | +$2.36M |
|
61
Scully Royalty
SRL
$81.5M
| $2.21M | 0.21% |
303,736
-6,786
| -2% | -$49.4K |
|
62
Perella Weinberg Partners
PWP
$1.33B
| $2.15M | 0.21% |
258,273
-247,020
| -49% | -$2.06M |
|
63
Structure Therapeutics
GPCR
$1.14B
| $2.08M | 0.2% |
50,000
| – | – |
|
|
AAN
64
DELISTED
The Aaron's Company, Inc.
AAN
| $1.96M | 0.19% |
138,572
-150,000
| -52% | -$2.12M |
|
65
Neuropace
NPCE
$310M
| $1.91M | 0.18% |
424,850
-1,075
| -0.3% | -$4.83K |
|
66
Spyre Therapeutics
SYRE
$1.02B
| $1.85M | 0.18% |
4,101,193
-456,819
| -10% | -$206K |
|
67
ADC Therapeutics
ADCT
$370M
| $1.81M | 0.17% |
840,000
| – | – |
|
68
AYTU BioPharma
AYTU
$21M
| $1.74M | 0.17% |
1,086,812
+815,217
| +300% | +$1.3M |
|
|
JBIO
69
Jade Biosciences, Inc. Common Stock
JBIO
$245M
| $1.63M | 0.16% |
95,000
| – | – |
|
70
Rezolute
RZLT
$630M
| $1.52M | 0.15% |
769,606
| – | – |
|
|
MACK
71
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
| $1.37M | 0.13% |
111,148
-80,118
| -42% | -$985K |
|
72
NN Inc
NNBR
$123M
| $1.26M | 0.12% |
+526,006
| New | +$1.26M |
|
73
ARS Pharmaceuticals
SPRY
$1.08B
| $1.21M | 0.12% |
+180,097
| New | +$1.21M |
|
74
Anebulo Pharmaceuticals
ANEB
$101M
| $1.2M | 0.12% |
511,073
| – | – |
|
75
Cartesian Therapeutics
RNAC
$267M
| $1.12M | 0.11% |
1,000,000
| – | – |
|